| P2093 | author name string | Angus A Wilfong | |
| | Amy D Malphrus | |
| P2860 | cites work | Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents | Q24245943 |
| | Seizure-alert dogs: a review and preliminary study | Q28207321 |
| | Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society | Q30496557 |
| | Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...] | Q33202375 |
| | Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the [...] | Q33202376 |
| | ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes | Q33252737 |
| | A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group | Q33865133 |
| | Surgical treatment of epilepsy. | Q34254797 |
| | A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy | Q34497514 |
| | Clinical aspects of the ketogenic diet | Q34604772 |
| | Pharmacologic treatment of the catastrophic epilepsies | Q35850450 |
| | Effectiveness of vagus nerve stimulation in epilepsy patients: a 12-year observation | Q35903464 |
| | Brain stimulation for epilepsy: can scheduled or responsive neurostimulation stop seizures? | Q36421606 |
| | Oxcarbazepine adjunctive therapy in infants and young children with partial seizures | Q40494462 |
| | Randomized trial of vigabatrin in patients with infantile spasms | Q43775105 |
| | Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet | Q44169569 |
| | Zonisamide treatment for symptomatic infantile spasms | Q44743467 |
| | Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy | Q46848043 |
| | Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy | Q46973040 |
| | Pediatric intractable epilepsy syndromes: reason for early surgical intervention | Q48438041 |
| | Epilepsy surgery in young children with tuberous sclerosis: results of a novel approach | Q48559136 |
| | Chronic anterior thalamus stimulation for intractable epilepsy | Q48583179 |
| | Practice parameter: treatment of the child with a first unprovoked seizure: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society | Q48637722 |
| | Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation | Q48685627 |
| | Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy. | Q53228992 |
| | Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study | Q61822712 |
| | Cognitive, psychosocial, and family function one year after pediatric epilepsy surgery | Q80090741 |
| | The impact of epilepsy surgery on quality of life in children | Q82676409 |
| | How long does it take for epilepsy to become intractable? A prospective investigation | Q83312164 |
| P433 | issue | 4 | |
| P304 | page(s) | 256-267 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | Current treatment options in neurology | Q26842298 |
| P1476 | title | Use of the newer antiepileptic drugs in pediatric epilepsies | |
| P478 | volume | 9 | |